|
|
|
23.05.26 - 15:30
|
Fraudster trying to sell fake ancient statues to Sotheby′s foiled over bogus invoices (The Guardian)
|
|
|
Paperwork supplied by Andrew Crowley, 46, found to be made using printing methods 25 years too modernA fraudster who tried to sell fake ancient statues to Sotheby's was foiled when his bogus accompanying paperwork was found to be written with printing methods that were 25 years too modern, a court has heard.Andrew Crowley, 46, asked the auctioneers to value three Cycladic figures and one Anatolian stargazer statuette that he had inherited from his grandfather, Southwark crown court in London was told on Friday. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
21.05.26 - 15:42
|
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now (24/7 Wall St.)
|
|
|
Moderna (NASDAQ:MRNA) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement. But the underlying story deserves a closer look. The Moderna Story Has Not Changed Strip away the bounce and the fundamentals tell the same story long-term investors have heard for three ... Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now...
|
|
|
|
|
|
|
|
|
|
|
|
|
13.05.26 - 10:13
|
Moderna: Vor dem großen Ausbruch (Der Aktionaer)
|
|
|
Nach dem heftigen Corona-Boom-Absturz läuft die Moderna-Aktie wieder heiß. Neue Fantasie liefert die Forschung an Impfstoffen zum Schutz vor Hantaviren. Der AKTIONÄR nimmt die Aktie neu ins Depot auf und setzt auf das enorme Comeback-Potenzial....
|
|
|
|
|
12.05.26 - 14:18
|
Heiko Thieme Club - Von LVMH bis Deutsche Bank: Kaufen, schwitzen, absichern. Matterhorn-Märkte: Wenn Euphorie steil wird. (BRN)
|
|
|
Die Märkte bewegen sich zwischen KI-Euphorie, Ölschock und geopolitischer Unsicherheit. Seine Diagnose: ein heißer Sommer an den Börsen, mit Chancen, aber auch mit spürbarem Risiko. Bei LVMH sieht er den Luxuswert nach rund 30 % Kursrückgang "kurz vor dem Kauf" und erklärt daran seine Drei-Tranchen-Strategie. Beim Verkauf bleibt er pragmatisch: Wer 25 % Gewinn hat, darf ein Drittel realisieren oder mit Stopps absichern. Bei ETFs gilt Ähnliches: Manuelas Batterie-ETF ist mit +70 % stark gelaufen, ein Stopp bei etwa +60 % wäre für ihn plausibel. BioNTech streicht Thieme dagegen weitgehend vom Zettel, Moderna bleibt für ihn interessanter. Im DAX-Check von BMW bis Deutsche Bank fällt sein Urteil differenziert aus: BMW neutral, Brenntag nach der Rally kein Neukauf, Commerzbank haltenswert, Continental nur mit Stopp, Daimler Truck möglich, aber kein Top-Favorit. Klar positiv wird er bei der Deutschen Bank: Nach dem Rücksetzer ist sie wieder kaufbar, idealerweise in Tranchen. Außerdem: Schaeffler ...
|
|
|
12.05.26 - 08:30
|
Moderna Hold (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Moderna auf "Hold" mit einem Kursziel von 45 US-Dollar belassen. Andrew Tsai bezog am Dienstag Stellung zur jüngsten Kursstärke, die unter anderem mit Spekulationen über einen ......
|
|
|
|
|
11.05.26 - 20:54
|
Trump Rejects Iran Offer as Tensions Rise | Open Interest 5/11/2026 (Bloomberg)
|
|
|
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Oil jumps as President Trump calls Iran's latest peace offer “totally unacceptable.” Moderna revives the biotech trade as officials race to contain a cruise ship-linked hantavirus outbreak. And KKR's $300 million rescue of a struggling credit fund raises fresh questions about private markets. Plus, Bruce Douglas on KKR's credit bet, Mary Ann Bartels believes a secular bear market will kickoff the next decade, Mike Pyle on AI investing, Flex CEO Revathi Advaithi, Starz CEO Jeffrey Hirsch, and Bond CEO Bill Papariella. (Source: Bloomberg)...
|
|
|
11.05.26 - 18:45
|
Moderna Extends Rally After Two More Cruise Ship Passengers Test Positive For Hantavirus (ZeroHedge)
|
|
|
Moderna Extends Rally After Two More Cruise Ship Passengers Test Positive For Hantavirus
Moderna shares are up another 7% in premarket trading, as renewed alarm over the hantavirus-plagued MV Hondius cruise ship energizes investor focus on the company's vaccine pipeline.
The latest news catalyst: Two passengers evacuated from the cruise ship on Sunday tested positive, reinforcing concerns that the outbreak remains active.
The Hondius is moored at a port in Spain's Canary Islands.
On Sunday, passengers were escorted off by personnel in protective gear before being flown home on government and military aircraft.
Seventeen Americans were taken to the University of Nebraska Medical Center, with one sent to the Nebraska Biocontainment Unit and the others placed in the National Quarantine Unit for monitoring.
The outbreak has killed three people, with five additional infections among passengers who had already left the ship.
Last Friday, we asked whether the vaccine trade is back, given news from ...
|
|
|
11.05.26 - 16:54
|
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? (24/7 Wall St.)
|
|
|
Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35. The intraday move extends what has already been a powerful 2026 run for the mRNA pioneer. The rally is outpacing fellow vaccine names Pfizer (NYSE:PFE), up 2% near $26.10, and Novavax (NASDAQ:NVAX), basically flat ... Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
